• Italy

in page functions
  • Italy flag

  • Proceeds to Gavi from donor contributions & pledges (2016-2020) as of 31 December 2016

     

     

    Note: Proceeds are funds made available to Gavi from donor contributions and commitments, either through cash payments made to Gavi, through frontloading via the capital markets of a future donor commitment to IFFIm, or through AMC funds released to Gavi via the World Bank. Future IFFIm proceeds from new pledges made at the Berlin pledging conference are indicative and are based on certain assumptions including future interest rates and foreign exchange rates generated from financial market data, and donor payment schedules. These assumptions may differ from conditions prevailing at the time of grant and legal agreement signing, which may result in different projected and realised IFFIm proceeds.

  • Contributions and pledges over time (US$ millions)

     

    Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
     

    Notes:
    Direct Contributions (including Matching Fund)
    Received contributions: non-US$ contributions for 2000-2016 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014, 2015 and 2016, where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.

    Future contributions: non-US$ Direct Contribution and Matching Fund pledges for years 2017 and beyond are expressed in US$ equivalents using the applicable 'forecast rates' from Bloomberg as at 31 December 2016 or using the rates applicable to any hedge agreement in place.

    IFFIm contributions
    Received contributions: non-US$ contributions for 2000-2016 are expressed in US$ equivalents as confirmed by the IBRD (World Bank)

    Future contributions: non-US$ contributions are expressed in US$ equivalents as follows:

    • Where the contribution agreement has been signed: contributions are expressed in US$ equivalents using the exchange rates at the time of signing the respective donor grant agreements
    • Where the contribution agreement has not yet been signed: non-US$ pledges for years 2017 and beyond are expressed in US$ equivalents using the applicable 'forecast rates' from Bloomberg as at 31 December 2016
    • These contributions have not been reduced by a notional 3% provision to allow for any potential reduction arising from the High Level Financing Condition of the IFFIm Finance Framework Agreement.

     

  • Funding history

    A key focus of Italy’s development strategy is to contribute to global health by strengthening the fight against inequalities in terms of the right to health (poorest countries, rural areas and suburbs, minorities and vulnerable groups). Their Global Health Strategy 2014-2016 is well aligned with Gavi’s mission through the focus on the health of women and children, prevention and control of infectious, chronic and non- communicable disease; and health system strengthening. In addition, Italy has a keen interest in innovative finance and their priority countries include all Gavi eligible countries in sub-Saharan Africa, Asia and Latin America (except El Salvador).

    Italy has contributed to the Vaccine Alliance since 2006 when they became a founding member of IFFIm and is its third largest contributor with a total commitment of EUR 492.3. Italy also took a leading role in launching the first AMC to accelerate the development and availability of pneumococcal vaccines. They are the largest donor to the AMC with a pledge of USD 635 million. At Gavi’s replenishment conference in Berlin 2015, Italy pledged an additional EUR 100 million in direct contributions for 2016-2020. The Government of Italy confirmed its support to Gavi on December 1, 2016 when the contribution agreement was signed in Rome.

    Contributions and pledges in total:

    • IFFIm: USD 608 million (EUR 492.3 million);
    • AMC (2008-2019): USD 635 million;
    • New pledge (2016-2020): EUR 100 million (USD 113.4 million) in direct funding.
close icon

modal window here